Law360, New York (February 22, 2007, 12:00 AM ET) -- In an attempt to horn in on the lucrative market for depression drug Lexapro, Caraco Pharmaceutical Laboratories Ltd. has filed a lawsuit looking to force a court ruling on a patent licensed to Forest Laboratories Holdings Ltd.
The lawsuit seeking declaratory judgment was filed in Michigan on Tuesday against defendants Forest Laboratories Inc., Forest Laboratories Holdings Ltd. and H. Lundbeck A/S.
The patents which the defendants claim cover Lexapro are U.S. Patent Numbers Re. 34,712 and 6,916,941. Forest has already sued Caraco for infringing the ‘712...
Caraco Seeks Judgment On Lexapro Patent
To view the full article, take a free trial now.
